TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development-Reference-Cited by-同舟云学术

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development

Published:2008-01-02 Issue:1 Volume:118 Page:100-110
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Grosse-Wilde Anne,Voloshanenko Oksana,Bailey S. Lawrence,Longton Gary M.,Schaefer Uta,Csernok Andreea I.,Schütz Günther,Greiner Erich F.,Kemp Christopher J.,Walczak Henning

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. TRAIL signalling: Decisions between life and death

2. Safety and antitumor activity of recombinant soluble Apo2 ligand

3. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

4. The promise of TRAIL—potential and risks of a novel anticancer therapy

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening;BMC Cancer;2024-06-27

2. Association of TRAIL receptor with phosphatase SHP-1 enables repressing T cell receptor signaling and T cell activation through inactivating Lck;Journal of Biomedical Science;2024-03-27

4. Apoptotic cell death in disease—Current understanding of the NCCD 2023;Cell Death & Differentiation;2023-04-26

5. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding;Science Advances;2023-03-24